BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10424770)

  • 1. Alteration of spinal protein kinase C expression and kinetics in morphine, but not clonidine, tolerance.
    Li Y; Roerig SC
    Biochem Pharmacol; 1999 Aug; 58(3):493-501. PubMed ID: 10424770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine.
    Fairbanks CA; Wilcox GL
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1107-16. PubMed ID: 10027848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased spinal morphine/clonidine antinociceptive synergism in morphine-tolerant mice.
    Roerig SC
    Life Sci; 1995; 56(5):PL115-22. PubMed ID: 7837926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice.
    Zeitz KP; Malmberg AB; Gilbert H; Basbaum AI
    Pain; 2001 Dec; 94(3):245-253. PubMed ID: 11731061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal morphine/clonidine antinociceptive synergism is regulated by protein kinase C, but not protein kinase A activity.
    Wei ZY; Roerig SC
    J Pharmacol Exp Ther; 1998 Dec; 287(3):937-43. PubMed ID: 9864276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-agatoxin IVA blocks spinal morphine/clonidine antinociceptive synergism.
    Roerig SC; Howse KM
    Eur J Pharmacol; 1996 Oct; 314(3):293-300. PubMed ID: 8957249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice.
    Smith FL; Javed RR; Smith PA; Dewey WL; Gabra BH
    Pharmacol Res; 2006 Dec; 54(6):474-80. PubMed ID: 17056270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotide knockdown of mGlu₅ receptor attenuates the antinociceptive tolerance and up-regulated expression of spinal protein kinase C associated with chronic morphine treatment.
    Xu T; Chen M; Zhou Q; Xue Y; Wang L; Bil De Arce VJ; Zhang X; Jiang W
    Eur J Pharmacol; 2012 May; 683(1-3):78-85. PubMed ID: 22429573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive activity of clonidine and its potentiation of morphine analgesia.
    Spaulding TC; Fielding S; Venafro JJ; Lal H
    Eur J Pharmacol; 1979 Sep; 58(1):19-25. PubMed ID: 499334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels.
    Wei ZY; Karim F; Roerig SC
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1392-407. PubMed ID: 8819527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic morphine-induced loss of the facilitative interaction between vasoactive intestinal polypeptide and delta-opioid: involvement of protein kinase C and phospholipase Cbetas.
    Liu NJ; Chakrabarti S; Gintzler AR
    Brain Res; 2004 Jun; 1010(1-2):1-9. PubMed ID: 15126111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice.
    Smith FL; Gabra BH; Smith PA; Redwood MC; Dewey WL
    Pain; 2007 Jan; 127(1-2):129-39. PubMed ID: 16965856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
    Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
    Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal and supraspinal agmatine activate different receptors to enhance spinal morphine antinociception.
    Roerig SC
    Ann N Y Acad Sci; 2003 Dec; 1009():116-26. PubMed ID: 15028575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal inflammation and morphine tolerance alter the interaction between morphine and clonidine on gastrointestinal transit in mice.
    Puig MM; Warner W; Pol O
    Anesthesiology; 2000 Jul; 93(1):219-30. PubMed ID: 10861166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant mice.
    Bernstein MA; Welch SP
    Brain Res; 1995 Oct; 696(1-2):83-8. PubMed ID: 8574689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the interaction between clonidine and morphine on analgesia and blood pressure during continuous intrathecal infusion in the rat.
    Loomis CW; Milne B; Cervenko FW
    Neuropharmacology; 1988 Feb; 27(2):191-9. PubMed ID: 3352873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the protein kinase Cgamma isoform in development of tolerance to nitrous oxide-induced antinociception in mice.
    Matsushita Y; Ishikawa M; Abe K; Utsunomiya I; Chikuma T; Hojo H; Hoshi K; Quock RM; Taguchi K
    Neuroscience; 2007 Aug; 148(2):541-7. PubMed ID: 17681696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.